<p>In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be using this agent in AML? Tune in to find out!</p>

In this episode, Bernie and Anthony are joined by Dr. Charlie Foucar and Dr. Anand Patel to review the interesting and controversy-filled saga of gemtuzumab in AML? Should we be using this agent in AML? Tune in to find out!

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!

Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Medicine

Health & Fitness

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Share LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

Sign up to save your podcasts

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

LFGooo! The Rise, the Fall, and the Resurrection of Gemtuzumab in AML

More shows like WolverHeme Happy Hour

Fresh Air

The NPR Politics Podcast

Pod Save America

The Daily

Up First from NPR

OncoPharm

Today, Explained

Interesting Times with Ross Douthat

Blood Podcast

ASTCT Talks

The Ezra Klein Show

The Weekly Show with Jon Stewart

Blood Cancer Talks

Two Onc Docs

The Headlines